|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | APOA5 gene polymorphism modulates levels of triglyceride, HDLcholesterol and FERHDL but is not a risk factor for coronary artery disease 显示文摘 | Kenny WJ Lee AF Ayyobi JJ | 2004 | Atherosclerosis2004，176，： | 1 |
| 2 | Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus显示文摘 | Brunzell JD Ayyobi AF | 2003 | Am J Med2003，115，8： | 1 |
| 3 | 显示文摘 | Deeb SS Zambon A Ayyobi AF | 2003 | J Lipid Res2003，44，7： | 1 |
| 4 | Dyslipdemia, in the metabolic syndrome and type 2 diabetes mellims显示文摘 | Brunzell JD Ayyobi AF | 2003 | Am J Meal2003，115，1： | 1 |
| 5 | APOA5 gene polymor- phism modulates levels of triglyceride ,HDL cholesterol and FER- HDL but is not a risk factor for coronary artery disease显示文摘 | Lee KW Ayyobi AF Frohlich JJ | 2004 | Ath- erosclerosis2004，176，1： | 1 |
| 6 | Lecithin: cholesterol acyltransferase (LCAT) deficiency and risk of vascular disease: 25 year follow-up 显示文摘 | AYYOBI A F MCGLADDERY S H CHAN S | 2004 | Atherosclerosis2004，177，2： | 1 |
| 7 | Small, dense LDL and elevated apolipoprotein B are the common characteristics for the three major lipid phenotypes of familial combined hyperlipidemia显示文摘 | Ayyobi AF McGladdery SH McNeely MJ | 2003 | Arte-rioscler Thromb Vase Biol2003，23，7： | 1 |
| 8 | Lipoprotein distribution in the metabolic syndrome, type 2 diabetes mellitus, and familial combined hyperlipidemia显示文摘 | AYYOBI A F BRUNZELL J D | 2003 | The American Journal of Cardi-ology2003，92，4： | 1 |
| 9 | Dyslipidemia in the metabolic syndrome and type2 diabetes mellitus显示文摘 | Brunzell JD Ayyobi AF | 2003 | Am J Med2003，115，8： | 1 |
| 10 | Lipoprotein distribution in the metabolic syndrome,type 2 diabetes mellitus,and familial combined hyperlipidemia显示文摘 | AYYOBI AF | 2003 | Am J Cardiol2003，92，4： | 1 |
| 11 | APOA5 gene polymorphism modulates levels of triglyceride,HDL cholesterol and FERHDL but is not a risk factor for coronary artery disease显示文摘 | Lee KW Ayyobi AF Frohlich JJ | 2004 | Atherosclerosis2004，176，1： | 1 |
| 12 | Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus显示文摘 | Brunzell JD Ayyobi AF | 2003 | Am J Med2003，115，8： | 1 |
| 13 | Dyslipdemia,in the metabolic syndrome and type 2 diabetes mellitus显示文摘 | Ayyobi AF | 2003 | Am J Med2003，115，： | 1 |
| 14 | Lipoprotein distribution in the metabolic syndrome,type 2 diabetes mellitus,and familial combined hyper- lipidemia显示文摘 | Ayyobi AF Brunzell JD | 2003 | Am J Cardiol2003，92，4： | 1 |
| 15 | Dyslipidemia in the metabolic syndromeand type 2 diabetes mellitus显示文摘 | Bruuzell JD Ayyobi AF | 2003 | Am J Med2003，115，： | 1 |
| 16 | APOA5 gene polymorphism modulates levels of triglyceride, HDL cholesterol and FER HDL but is not a risk factor for coronary artery disease显示文摘 | Kenny W.J Lee Amir F Ayyobi Jiri J Frohlich John S Hill | 2004 | Atherosclerosis2004，，1： | 1 |
| 17 | Dyslipidemia in the metabolic syndrome and type 2 diabete smellitus 显示文摘 | Brunzell JD Ayyobi AF | 2003 | AMJ Med2003，，： | 1 |
| 18 | Dyslipdemia,in the metabolic syndrome and type 2 diabetes meUitus显示文摘 | Brunzell JD Ayyobi AF | 2003 | A m J Meal2003，115，1： | 1 |
| 19 | ApoAⅤ gene polymorphism modulates levels of triglyceride,HDL cholesterol and FERHDL but is not a risk factor for coronary artery disease显示文摘 | Lee KW Ayyobi AF Frohlich JJ | 2004 | Atherosclerosis2004，176，1： | 1 |
| 20 | Hepatic lipase and dyslipidemia :interactions among genetic variants, obesity, gender, and diet显示文摘 | Deeb SS Zambon A Ayyobi AF | 2003 | J Lipid Res2003，44，7： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员